AAAAAA

   
Results: 1-15 |
Results: 15
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivity
Authors: Coronnello, M Marcon, G Carotti, S Caciagli, B Mini, E Mazzei, T Orioli, P Messori, L
Citation: M. Coronnello et al., Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivity, ONCOL RES, 12(9-10), 2001, pp. 361-370
Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients
Authors: Di Paolo, A Danesi, R Falcone, A Cionini, L Vannozzi, F Masi, G Allegrini, G Mini, E Bocci, G Conte, PF Del Tacca, M
Citation: A. Di Paolo et al., Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients, ANN ONCOL, 12(9), 2001, pp. 1301-1306
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma
Authors: Martoni, A Mini, E Pinto, C Nobili, S Gentile, AL Dentico, P Angelelli, B Scicolone, S Piana, E Mazzei, T
Citation: A. Martoni et al., Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma, ANN ONCOL, 12(4), 2001, pp. 519-524
Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides
Authors: Morganti, M Coronnello, M Caciagli, B Biondi, C Quattrone, A Capaccioli, S Mazzei, T Mini, E
Citation: M. Morganti et al., Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides, ANTI-CANC D, 11(4), 2000, pp. 285-294
Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro
Authors: Noci, I Coronnello, M Borri, P Borrani, E Giachi, M Chieffi, O Marchionni, M Paglierani, M Buccoliero, AM Cherubini, A Arcangeli, A Mini, E Taddei, G
Citation: I. Noci et al., Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro, CANCER LETT, 150(1), 2000, pp. 71-78
Clinicopathologic features and FHIT gene expression in sporadic colorectaladenocarcinomas
Authors: Luceri, C Guglielmi, F De Filippo, C Caderni, G Mini, E Biggeri, A Napoli, C Tonelli, F Cianchi, F Dolara, P
Citation: C. Luceri et al., Clinicopathologic features and FHIT gene expression in sporadic colorectaladenocarcinomas, SC J GASTR, 35(6), 2000, pp. 637-641
Gold(III) complexes as potential antitumor agents: Solution chemistry and cytotoxic properties of some selected gold(III) compounds
Authors: Messori, L Abbate, F Marcon, G Orioli, P Fontani, M Mini, E Mazzei, T Carotti, S O'Connell, T Zanello, P
Citation: L. Messori et al., Gold(III) complexes as potential antitumor agents: Solution chemistry and cytotoxic properties of some selected gold(III) compounds, J MED CHEM, 43(19), 2000, pp. 3541-3548
Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor
Authors: Peri, A Bonaccorsi, L Muratori, M Luconi, M Baldi, E Granchi, S Pesciullesi, A Mini, E Cioppi, F Forti, G Serio, M Miele, L Maggi, M
Citation: A. Peri et al., Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor, INT J CANC, 88(4), 2000, pp. 525-534
Resistance to methotrexate in SKOV-3 cell lines after chronic exposure to carbamazepine is associated with a decreased expression of folate receptor
Authors: Toffoli, G Corona, G Tolusso, B Sartor, F Sorio, R Mini, E Boiocchi, M
Citation: G. Toffoli et al., Resistance to methotrexate in SKOV-3 cell lines after chronic exposure to carbamazepine is associated with a decreased expression of folate receptor, INT J CANC, 85(5), 2000, pp. 683-690
Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu)
Authors: Carotti, S Marcon, G Marussich, M Mazzei, T Messori, L Mini, E Orioli, P
Citation: S. Carotti et al., Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu), CHEM-BIO IN, 125(1), 2000, pp. 29-38
Marked variation of thymidylate synthase and folylpolyglutamate synthetasegene expression in human colorectal tumors
Authors: Mini, E Biondi, C Morganti, M Napoli, C Mazzoni, P Cianchi, F Tonelli, F Cortesini, C Capaccioli, S Ficari, F Quattrone, A Rossi, S Mazzei, T
Citation: E. Mini et al., Marked variation of thymidylate synthase and folylpolyglutamate synthetasegene expression in human colorectal tumors, ONCOL RES, 11(9), 1999, pp. 437-445
Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery
Authors: Periti, P Stringa, G Mini, E
Citation: P. Periti et al., Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery, EUR J CL M, 18(2), 1999, pp. 113-119
Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin (vol 41, pg 329, 1998)
Authors: Periti, P Mini, E Mosconi, G
Citation: P. Periti et al., Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin (vol 41, pg 329, 1998), J ANTIMICRO, 42(6), 1998, pp. 840-840
Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin (vol 41, pg 329, 1988)
Authors: Periti, P Mini, E Mosconi, G
Citation: P. Periti et al., Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin (vol 41, pg 329, 1988), J ANTIMICRO, 42(5), 1998, pp. 682-682
Differential inhibitory effects on human endometrial carcinoma cell growthof luteinizing hormone-releasing hormone analogues
Authors: Borri, P Coronnello, M Noci, I Pesciullesi, A Peri, A Caligiani, R Maggi, M Torricelli, F Scarselli, G Chieffi, O Mazzei, T Mini, E
Citation: P. Borri et al., Differential inhibitory effects on human endometrial carcinoma cell growthof luteinizing hormone-releasing hormone analogues, GYNECOL ONC, 71(3), 1998, pp. 396-403
Risultati: 1-15 |